PCAF-IN-2 (compound 17) is a potent PCAF inhibitor with an IC 50 value of 5.31 µM. PCAF-IN-2 shows anti-tumour activity. CAF-IN-2 induces apoptosis and arrest the cell cycle at the G2/M phaseIn VitroPCAF-IN-2 shows anti-tumour activity with IC 50 s
PCAF-IN-2 (compound 17) is a potent PCAF inhibitor with an IC 50 value of 5.31 µM. PCAF-IN-2 shows anti-tumour activity. CAF-IN-2 induces apoptosis and arrest the cell cycle at the G2/M phaseIn VitroPCAF-IN-2 shows anti-tumour activity with IC 50 s
PCAF-IN-2 (compound 17) is a potent PCAF inhibitor with an IC 50 value of 5.31 µM. PCAF-IN-2 shows anti-tumour activity. CAF-IN-2 induces apoptosis and arrest the cell cycle at the G2/M phaseIn VitroPCAF-IN-2 shows anti-tumour activity with IC 50 s
PCAF-IN-2 (compound 17) is a potent PCAF inhibitor with an IC 50 value of 5.31 µM. PCAF-IN-2 shows anti-tumour activity. CAF-IN-2 induces apoptosis and arrest the cell cycle at the G2/M phaseIn VitroPCAF-IN-2 shows anti-tumour activity with IC 50 s
PCAF-IN-2 (compound 17) is a potent PCAF inhibitor with an IC 50 value of 5.31 µM. PCAF-IN-2 shows anti-tumour activity. CAF-IN-2 induces apoptosis and arrest the cell cycle at the G2/M phaseIn VitroPCAF-IN-2 shows anti-tumour activity with IC 50 s
PCAF-IN-2 (compound 17) is a potent PCAF inhibitor with an IC 50 value of 5.31 µM. PCAF-IN-2 shows anti-tumour activity. CAF-IN-2 induces apoptosis and arrest the cell cycle at the G2/M phaseIn VitroPCAF-IN-2 shows anti-tumour activity with IC 50 s